Correction to: Mol Cancer 17, 157 (2018)
https://doi.org/10.1186/s12943-018-0906-x
Following publication of the original article [1], a minor error was identified in the images presented in Fig. 1; specifically:
Fig. 1F: incorrect image used for representative image of invasive cells induced by transfection of miR-452-5p in OSRC-2 with treatment of 10 μM Sunitinib (top left image); the image has been corrected.
The corrected figure is given here. The correction does not have any effect on the results or conclusions of the paper.
Reference
Zhai W, Li S, Zhang J, et al. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals. Mol Cancer. 2018;17:157. https://doi.org/10.1186/s12943-018-0906-x.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhai, W., Li, S., Zhang, J. et al. Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals. Mol Cancer 21, 96 (2022). https://doi.org/10.1186/s12943-022-01568-y
Published:
DOI: https://doi.org/10.1186/s12943-022-01568-y